Rabeprazole is effective in treating laryngopharyngeal reflux in a randomized placebo-controlled trial

Clinical Gastroenterology and Hepatology

Volumn 8, Issue 9, 2010, Pages 770-776

  Lam, Paul K Y ^a   Ng, Manwa L ^a   Cheung, Ting K ^a   Wong, Birgitta Y H ^a   Tan, Victoria P Y ^a   Fong, Daniel Y T ^a   Wei, William I ^a   Wong, Benjamin C Y ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Double Blind; Laryngopharyngeal Reflux; Proton Pump Inhibitor; Rabeprazole

Indexed keywords

ESOMEPRAZOLE; LANSOPRAZOLE; OMEPRAZOLE; PANTOPRAZOLE; PLACEBO; RABEPRAZOLE;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; HUMAN; LARYNGOPHARYNGEAL REFLUX; MAJOR CLINICAL STUDY; MALE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; STRUCTURED QUESTIONNAIRE; VIDEOENDOSCOPY;

EID: 77956171980     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2010.03.009     Document Type: Article

References (26)

1. Koufman J.A., Amin M.R., Panetti M. Prevalence of reflux in 113 consecutive patients with laryngeal and voice disorders. Otolaryngol Head Neck Surg 2000, 123:385-388.
2. Smit C.F., van Leeuwen J.A., Mathus-Vliegen L.M., et al. Gastropharyngeal and gastroesophageal reflux in globus and hoarseness. Arch Otolaryngol Head Neck Surg 2000, 126:827-830.
3. Noordzij J.P., Khidr A., Desper E., et al. Correlation of pH probe measured laryngopharyngeal reflux with symptoms and signs of reflux laryngitis. Laryngoscope 2002, 112:2192-2195.
4. Lam P., Wei W.I., Hui Y., et al. Prevalence of pH-documented laryngopharyngeal reflux in Chinese patients with clinically suspected reflux laryngitis. Am J Otolaryngol 2006, 27:186-189.
5. Weiner G.J., Koufman J.A., Wu W.C., et al. Chronic hoarseness secondary to gastroesophageal reflux disease: documentation with 24-hr ambulatory pH monitoring. Am J Gastroenterol 1989, 84:1503-1508.
6. Wiener G.J., Cooper J.B., Wu W.C. Reflux laryngitis and its sequelae: the diagnostic role of ambulatory 24-hour pH monitoring. J Voice 1988, 2:78-79.
7. Vincent D.A., Garrett J.D., Radionoff S.L., et al. The proximal probe in oesophageal pH monitoring: development of a normative database. J Voice 2000, 14:247-254.
8. Karkos P.D., Wilson J.A. Empiric treatment of laryngopharyngeal reflux with proton pump inhibitors: a systematic review. Laryngoscope 2006, 116:144-148.
9. Qadeer M.A., Phillips C.O., Lopez A.R., et al. Proton pump inhibitor therapy for suspected GERD-related chronic laryngitis: a meta-analysis of randomized controlled trials. Am J Gastroenterol 2006, 101:2646-2654.
10. Belafsky P.C., Postma G.N., Koufman J.A. The validity and reliability of the reflux finding score (RFS). Laryngoscope 2001, 111:1313-1317.
11. Hu W.H., Wong N.Y., Lai K.C., et al. Normal 24-hour ambulatory proximal and distal gastroesophageal reflux parameters in Chinese. Hong Kong Med J 2002, 8:168-171.
12. Belafsky P.C., Postma G.N., Koufman J.A. Validity and reliability of the reflux symptom index (RSI). J Voice 2002, 16:274-277.
13. Vaezi M.F., Richter J.E., Stasney C.R., et al. Treatment of chronic posterior laryngitis with esomeprazole. Laryngoscope 2006, 116:254-260.
14. Wo J.M., Koopman J.I., Harrell S.P., et al. Double-blind, placebo-controlled trial with single-dose pantoprazole for laryngopharyngeal reflux. Am J Gastroenterol 2006, 101:1972-1978.
15. Steward D.L., Wilson K.M., Kelly D.H., et al. Proton pump inhibitor therapy for chronic laryngo-pharyngitis: a randomized placebo-control trial. Otolaryngol Head Neck Surg 2004, 131:342-350.
16. Eherer A.J., Habermann W., Hammer H.F., et al. Effect of pantoprazole on the course of reflux-associated laryngitis: a placebo-controlled double-blind crossover study. Scand J Gastroenterol 2003, 38:462-467.
17. El-Serag H.B., Lee P., Buchner A., et al. Lansoprazole treatment of patients with chronic idiopathic laryngitis: a placebo-controlled trial. Am J Gastroenterol 2001, 96:979-983.
18. Noordzij J.P., Khidr A., Evans B.A., et al. Evaluation of omeprazole in the treatment of reflux laryngitis: a prospective, placebo-controlled, randomized, double-blind study. Laryngoscope 2001, 111:2147-2151.
19. Langevin S., Hanh N. GERD-induced ENT symptoms: a prospective placebo controlled study with omeprazole 40 mg a day. Gastroenterology 2001, 120:A-16-17.
20. Havas T., Huang S., Levy M., et al. Posterior pharyngolaryngitis. Double blind randomized placebo-controlled trial of proton pump inhibitor therapy. Aust J Otolaryng 1999, 3:243-246.
21. Kamel P.L., Hanson D., Kahrilas P.J. Omeprazole for the treatment of posterior laryngitis. Am J Med 1994, 96:321-326.
22. Young J.L., Shaw G.Y., Searl J.P., et al. Laryngeal manifestations of gastroesophageal reflux disease: endoscopic appearance and management. Gastrointest Endosc 1996, 43:225-230.
23. Reichel O., Dressel H., Wiederänders K., et al. Double-blind, placebo-controlled trial with esomeprazole for symptoms and signs associated with laryngopharyngeal reflux. Otolaryngol Head Neck Surg 2008, 139:414-420.
24. Belafsky P.C., Postma G.N., Koufman J.A., et al. Laryngopharyngeal reflux symptoms improve before changes in physical findings. Laryngoscope 2001, 111:979-981.
25. Oyer S.L., Anderson L.C., Halum S.L. Influence of anxiety and depression on the predictive value of the reflux symptom index. Ann Otol Rhinol Laryngol 2009, 118:687-692.
26. Kotby M.N., Hassan O., El-Makhzangy A.M.N., et al. Gastroesophageal reflux/laryngopharyngeal reflux disease: a critical analysis of the literature. Eur Arch Otorhinolaryngol 2010, 267:171-179.